NANOSYRINGE Trademark

Trademark Overview


On Monday, July 14, 2025, a trademark application was filed for NANOSYRINGE with the United States Patent and Trademark Office. The USPTO has given the NANOSYRINGE trademark a serial number of 79437925. The federal status of this trademark filing is NON-FINAL ACTION COUNTED - NOT MAILED as of Wednesday, December 10, 2025. This trademark is owned by NANOSYRINX LTD. The NANOSYRINGE trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and veterinary preparations for the targeted intracellular delivery of biological molecules, drugs and therapeutic substances; pharmaceutical preparations and substances for the targeted intracellular delivery of biological molecules, drugs and therapeutic substances; pharmaceutical compositions and preparations for the targeted intracellular delivery of biological molecules, drugs and therapeutic substances; pharmaceutical preparations for intracellular delivery of drugs; veterinary preparations for intracellular delivery of drugs; pharmaceutical preparations for intracellular delivery of antibodies; veterinary preparations for intracellular delivery of antibodies; pharmaceutical preparations for intracellular delivery of enzymes; veterinary preparations for intracellular delivery of enzymes; pharmaceutical preparations for intracellular delivery of antibody fragments; veterinary preparations for intracellular delivery of antibody fragments; pharmaceutical preparations ...

Scientific and technological services and research and design relating thereto relating to the targeted intracellular delivery of biological molecules, drugs and therapeutics; research services relating to the targeted intracellular delivery of biological molecules, drugs and therapeutics; biotechnological research services relating to the targeted intracellular delivery of biological molecules, drugs and therapeutics; drug discovery services relating to the targeted intracellular delivery of biological molecules, drugs and therapeutics; clinical trials relating to the targeted intracellular delivery of biological molecules, drugs and therapeutics; development of pharmaceutical preparations and medicines for the targeted intracellular delivery of biological molecules, drugs and therapeutics; laboratory research services relating to pharmaceuticals for the targeted intracellular delivery of biological molecules, drugs and therapeutics; medical laboratories; medical laboratory services; ...

Micro-organisms, cultures and preparations of micro-organisms, other than for medical and veterinary use, for the targeted intracellular delivery of biological molecules; chemical products and substances for use in science and industry for the targeted intracellular delivery of biological molecules; chemical products and substances for in vitro use for the targeted intracellular delivery of biological molecules; cell cultures except for medical and veterinary purposes; chemicals for analysis in laboratories; media for cell culture for use in the biotechnological industry; cultures of cell media [other than for medical or veterinary use]; nutritive agents for processing living cells [other than for medical use] for the targeted intracellular delivery of biological molecules; biological preparations for use in cell cultures, other than for medical or veterinary use, for the targeted intracellular delivery of biological molecules; chemicals and polymers for use in the pharmaceutical indus...
nanosyringe

General Information


Serial Number79437925
Word MarkNANOSYRINGE
Filing DateMonday, July 14, 2025
Status640 - NON-FINAL ACTION COUNTED - NOT MAILED
Status DateWednesday, December 10, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical and veterinary preparations for the targeted intracellular delivery of biological molecules, drugs and therapeutic substances; pharmaceutical preparations and substances for the targeted intracellular delivery of biological molecules, drugs and therapeutic substances; pharmaceutical compositions and preparations for the targeted intracellular delivery of biological molecules, drugs and therapeutic substances; pharmaceutical preparations for intracellular delivery of drugs; veterinary preparations for intracellular delivery of drugs; pharmaceutical preparations for intracellular delivery of antibodies; veterinary preparations for intracellular delivery of antibodies; pharmaceutical preparations for intracellular delivery of enzymes; veterinary preparations for intracellular delivery of enzymes; pharmaceutical preparations for intracellular delivery of antibody fragments; veterinary preparations for intracellular delivery of antibody fragments; pharmaceutical preparations for gene editing; veterinary preparations for gene editing; pharmaceutical preparations for intracellular delivery of therapeutic substances focused on the development of RNA therapies; veterinary preparations for intracellular delivery of therapeutic substances focused on the development of RNA therapies; pharmaceutical preparations for intracellular delivery of therapeutic substances focused on non-viral delivery technology; veterinary preparations for intracellular delivery of therapeutic substances focused on non-viral delivery technology; pharmaceutical preparations for intracellular delivery of nucleic acids; veterinary preparations for intracellular delivery of nucleic acids; pharmaceutical preparations for intracellular delivery of proteins; veterinary preparations for intracellular delivery of proteins; pharmaceutical preparations for intracellular delivery of peptides; veterinary preparations for intracellular delivery of peptides; pharmaceutical preparations for intracellular delivery of small molecules; veterinary preparations for intracellular delivery of small molecules; pharmaceutical substances for intracellular delivery of drugs; pharmaceutical substances for gene editing; pharmaceutical substances for intracellular delivery of therapeutic substances focused on the development of RNA therapies; pharmaceutical substances for intracellular delivery of therapeutic substances focused on non-viral delivery technology; pharmaceutical substances for intracellular delivery of nucleic acids; pharmaceutical substances for intracellular delivery of proteins; pharmaceutical preparations for intracellular delivery peptides; pharmaceutical substances for intracellular delivery of peptides; drug delivery agents for the targeted intracellular delivery of biological molecules, drugs and therapeutics; drug delivery agents that facilitate the intracellular delivery of pharmaceutical preparations; biological pharmaceuticals for the targeted intracellular delivery of biological molecules, drugs and therapeutics; drug delivery agents for delivering pharmaceuticals to target cells; agents for delivering proteins to target cells; agents for delivering peptides to target cells; bacterial preparations for pharmaceutical purposes for the targeted intracellular delivery of biological molecules, drugs and therapeutics; bacterial preparations for medical purposes for the targeted intracellular delivery of biological molecules, drugs and therapeutics; micro-organisms, bacteria and cultures and preparations of micro-organisms for medical and veterinary use; media for the storage of micro-organisms and bacteria, bacteriological cultures; nutritive substances for micro-organisms; bacterial cultures for medical and veterinary use; cultures of microorganisms for medical and veterinary use; bacterial and bacteriological preparations for medical or veterinary use for the targeted intracellular delivery of biological molecules, drugs and therapeutics; diagnostic preparations and substances; pharmaceutical and veterinary preparations and substances for the targeted intracellular delivery of biological molecules, drugs and therapeutics; diagnostic preparations and substances, all for in vivo use; cell preparations for medical and veterinary purposes, nutrients for cell cultures; living cells for medical use; genetically-encoded protein complexes capable of binding to cell-surface antigens, for delivering biological molecules, drugs and therapeutics to target cells, for medical or veterinary use; genetically-encoded protein assemblies capable of binding to cell-surface antigens, for delivering biological molecules, drugs and therapeutics to target cells, for medical or veterinary use.
Pseudo MarkNANO SYRINGE
Goods and ServicesScientific and technological services and research and design relating thereto relating to the targeted intracellular delivery of biological molecules, drugs and therapeutics; research services relating to the targeted intracellular delivery of biological molecules, drugs and therapeutics; biotechnological research services relating to the targeted intracellular delivery of biological molecules, drugs and therapeutics; drug discovery services relating to the targeted intracellular delivery of biological molecules, drugs and therapeutics; clinical trials relating to the targeted intracellular delivery of biological molecules, drugs and therapeutics; development of pharmaceutical preparations and medicines for the targeted intracellular delivery of biological molecules, drugs and therapeutics; laboratory research services relating to pharmaceuticals for the targeted intracellular delivery of biological molecules, drugs and therapeutics; medical laboratories; medical laboratory services; medical research relating to the targeted intracellular delivery of biological molecules, drugs and therapeutics; medical research services relating to the targeted intracellular delivery of biological molecules, drugs and therapeutics; pharmaceutical drug development services relating to the targeted intracellular delivery of biological molecules, drugs and therapeutics; pharmaceutical research and development relating to the targeted intracellular delivery of biological molecules, drugs and therapeutics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials relating to the targeted intracellular delivery of biological molecules, drugs and therapeutics; research and development of vaccines and medicines relating to the targeted intracellular delivery of biological molecules, drugs and therapeutics; research of pharmaceuticals relating to the targeted intracellular delivery of biological molecules, drugs and therapeutics; research relating to medicines relating to the targeted intracellular delivery of biological molecules, drugs and therapeutics; research relating to pharmaceuticals for the targeted intracellular delivery of biological molecules, drugs and therapeutics; scientific investigations for medical purposes relating to the targeted intracellular delivery of biological molecules, drugs and therapeutics; scientific research and development relating to the targeted intracellular delivery of biological molecules, drugs and therapeutics; scientific research in the field of pharmacy relating to the targeted intracellular delivery of biological molecules, drugs and therapeutics; services for assessing the efficacy of pharmaceuticals relating to the targeted intracellular delivery of biological molecules, drugs and therapeutics; research and development in the field of drug delivery relating to the targeted intracellular delivery of biological molecules, drugs and therapeutics; research and development in the field of gene editing; scientific and technological services and research and design relating to genetically-encoded protein complexes and protein assemblies capable of binding to cell-surface antigens, for delivering biological molecules, drugs and therapeutics to target cells; biotechnological research services relating to genetically-encoded protein complexes and protein assemblies capable of binding to cell-surface antigens, for delivering biological molecules, drugs and therapeutics to target cells; drug discovery services relating to genetically-encoded protein complexes and protein assemblies capable of binding to cell-surface antigens, for delivering biological molecules, drugs and therapeutics to target cells; clinical trials relating to genetically-encoded protein complexes and protein assemblies capable of binding to cell-surface antigens, for delivering biological molecules, drugs and therapeutics to target cells; laboratory research services relating to genetically-encoded protein complexes and protein assemblies capable of binding to cell-surface antigens, for delivering biological molecules, drugs and therapeutics to target cells; medical research relating to genetically-encoded protein complexes and protein assemblies capable of binding to cell-surface antigens, for delivering biological molecules, drugs and therapeutics to target cells; pharmaceutical drug development services relating to genetically-encoded protein complexes and protein assemblies capable of binding to cell-surface antigens, for delivering biological molecules, drugs and therapeutics to target cells; pharmaceutical research and development relating to genetically-encoded protein complexes and protein assemblies capable of binding to cell-surface antigens, for delivering biological molecules, drugs and therapeutics to target cells; providing medical and scientific research information in the field of genetically-encoded protein complexes and protein assemblies capable of binding to cell-surface antigens, for delivering biological molecules, drugs and therapeutics to target cells; research and development of vaccines and medicines relating to genetically-encoded protein complexes and protein assemblies capable of binding to cell-surface antigens, for delivering biological molecules, drugs and therapeutics to target cells; services for assessing the efficacy of pharmaceuticals relating to genetically-encoded protein complexes and protein assemblies capable of binding to cell-surface antigens, for delivering biological molecules, drugs and therapeutics to target cells; research and development in the field of drug delivery relating to genetically-encoded protein complexes and protein assemblies capable of binding to cell-surface antigens, for delivering biological molecules, drugs and therapeutics to target cells; information, advisory and consultancy services relating to all of the aforesaid.
Goods and ServicesMicro-organisms, cultures and preparations of micro-organisms, other than for medical and veterinary use, for the targeted intracellular delivery of biological molecules; chemical products and substances for use in science and industry for the targeted intracellular delivery of biological molecules; chemical products and substances for in vitro use for the targeted intracellular delivery of biological molecules; cell cultures except for medical and veterinary purposes; chemicals for analysis in laboratories; media for cell culture for use in the biotechnological industry; cultures of cell media [other than for medical or veterinary use]; nutritive agents for processing living cells [other than for medical use] for the targeted intracellular delivery of biological molecules; biological preparations for use in cell cultures, other than for medical or veterinary use, for the targeted intracellular delivery of biological molecules; chemicals and polymers for use in the pharmaceutical industry for the targeted intracellular delivery of biological molecules; proteins for scientific research and development for the targeted intracellular delivery of biological molecules; peptide preparations for use in the manufacture of pharmaceuticals and for the targeted intracellular delivery of biological molecules; proteins for use in science for the targeted intracellular delivery of biological molecules; laboratory reagents for scientific use for the targeted intracellular delivery of biological molecules; laboratory reagents for the targeted intracellular delivery of peptides, proteins, enzymes, gene editing enzymes, antibodies or antibody fragments; genetically-encoded protein complexes capable of binding to cell-surface antigens, for delivering biological molecules to target cells, other than for medical use; genetically-encoded protein assemblies capable of binding to cell-surface antigens, for delivering biological molecules to target cells, other than for medical use.

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, November 27, 2025
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 27, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 27, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNANOSYRINX LTD
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, November 27, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, December 2, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 2, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, December 3, 2025ASSIGNED TO EXAMINER
Wednesday, December 10, 2025NON-FINAL ACTION WRITTEN
Thursday, December 11, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW